The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with control mice, p53-deficient mice develop atherosclerosis more quickly in the presence of comparable serum cholesterol levels.305”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [305]
In the citing paper
“More importantly, compared with those in control mice, the atherosclerotic sites in p53-deficient mice presented a remarkable increase in the cell proliferation rate and an insignificant increase in apoptosis.305”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [305]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Practical Nonparametric Statistics (2nd ed).
Groeneveld, R. A., & Conover, W. J. (1981) · Journal of the American Statistical Association · doi:10.2307/2287607 · Cited by 1,849
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693 · cited 1×
“Post-angioplasty coronary restenosis, an aggressive form of atherosclerosis, is associated with the accumulation of p53 in this lesion, which also correlates with the presence of human cytomegalovirus in the lesio”
BackgroundPotential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Apoptosis in Human Atherosclerosis and Restenosis
Isner, J. M., Kearney, M., Bortman, S., & Passeri, J. (1995) · Circulation · doi:10.1161/01.cir.91.11.2703 · Cited by 672
Geng, Y., & Libby, P. (1995) · Europe PMC (PubMed Central) · Cited by 640
Cited by
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
“It is also noteworthy that p53 dysfunction is associated with inflammatory diseases and atherosclerosis 96,97 , indicating that pharmacological modulation of p53, and its upstream activator ATM, might ameliorate such pathologies 85 .”
BackgroundLusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans
Holdt, L. M., Stahringer, A., Sass, K., Pichler, G., Kulak, N. A., Wilfert, W., Kohlmaier, A., Herbst, A., Northoff, B. H., Nicolaou, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12429 · Cited by 1,094
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Collins, R. G., Velji, R., Guevara, N. V., Hicks, M. J., Chan, L., & Beaudet, A. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.189 · Cited by 493
Self-citationWu, G., Cai, J., Han, Y., Chen, J., Huang, Z.-P., Chen, C., Cai, Y., Huang, H., Yang, Y., Liu, Y., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.011675 · Cited by 485
Insulin resistance and atherosclerosis
Semenkovich, C. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29024 · Cited by 481
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice
Paul, A., Ko, K. W. S., Li, L., Yechoor, V., McCrory, M. A., Szalai, A. J., & Chan, L. (2004) · Circulation · doi:10.1161/01.cir.0000114526.50618.24 · Cited by 373
Self-citationKunieda, T., Minamino, T., Nishi, J.-I., Tateno, K., Oyama, T., Katsuno, T., Miyauchi, H., Orimo, M., Okada, S., Takamura, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.626606 · Cited by 302
Apoptosis in atherosclerosis: beneficial or detrimental?
Kockx, M. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00235-7 · Cited by 311
High-level expression of Egr-1 and Egr-1–inducible genes in mouse and human atherosclerosis
McCaffrey, T. A., Fu, C., Du, B., Eksinar, S., Kent, K. C., Bush, H., Kreiger, K., Rosengart, T., Cybulsky, M. I., Silverman, E. S., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8592 · Cited by 294
Progression of Atheroma: A Struggle Between Death and Procreation
Geng, Y.-J., & Libby, P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000031341.84618.a4 · Cited by 288
Plaque Rupture in Humans and Mice
Schwartz, S. M., Galis, Z. S., Rosenfeld, M. E., & Falk, E. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000261709.34878.20 · Cited by 255
von der Thüsen, J. H., van Vlijmen, B. J. M., Hoeben, R. C., Kockx, M. M., Havekes, L. M., van Berkel, T. J. C., & Biessen, E. A. L. (2002) · Circulation · doi:10.1161/01.cir.0000015502.97828.93 · Cited by 203
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
Stein, S., Lohmann, C., Schäfer, N., Hofmann, J., Rohrer, L., Besler, C., Rothgiesser, K. M., Becher, B., Hottiger, M. O., Borén, J., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq107 · Cited by 188
Hannou, S. A., Wouters, K., Paumelle, R., & Staels, B. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.01.008 · Cited by 159
Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program
Blagosklonny, M. V. (2010) · Cell Cycle · doi:10.4161/cc.9.16.13120 · Cited by 160
p53-Dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions
Gorgoulis, V. G., Pratsinis, H., Zacharatos, P., Demoliou, C., Sigala, F., Asimacopoulos, P. J., Papavassiliou, A. G., & Kletsas, D. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700241 · Cited by 122
Macrophage proliferation and apoptosis in atherosclerosis
Andrés, V., Pello, O. M., & Silvestre-Roig, C. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328357a379 · Cited by 74
“apoE-KO p53 global inactivation Increased intimal cell proliferation Increase [24]”
BackgroundInfluentialp53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice
Cao, R. Y., Eves, R., Jia, L., Funk, C. D., Jia, Z., & Mak, A. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175061 · Cited by 22
Metadata
- Authors
- Guevara, N. V., Kim, H.-S., Antonova, E. I., & Chan, L.
- Venue
- Nature Medicine
- Published
- 1999-03
- Volume
- 5
- Issue
- 3
- Pages
- 335-339
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/6585
- OpenAlex
- W1606722513
- Cited by
- 286
- References
- 23
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.